nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP2D6—Lomustine—brain cancer	0.185	0.271	CbGbCtD
Granisetron—CYP2D6—Hydroxyurea—brain cancer	0.14	0.205	CbGbCtD
Granisetron—CYP3A4—Temozolomide—brain cancer	0.139	0.203	CbGbCtD
Granisetron—CYP3A4—Lomustine—brain cancer	0.118	0.172	CbGbCtD
Granisetron—CYP3A5—Etoposide—brain cancer	0.073	0.107	CbGbCtD
Granisetron—HTR3A—fourth ventricle—brain cancer	0.0371	0.474	CbGeAlD
Granisetron—CYP3A4—Etoposide—brain cancer	0.0285	0.0417	CbGbCtD
Granisetron—HTR3A—cranial nerve—brain cancer	0.0132	0.169	CbGeAlD
Granisetron—HTR3A—ganglion—brain cancer	0.0067	0.0855	CbGeAlD
Granisetron—HTR3A—brainstem—brain cancer	0.00291	0.0372	CbGeAlD
Granisetron—HTR3A—telencephalon—brain cancer	0.00258	0.033	CbGeAlD
Granisetron—CYP2D6—hindbrain—brain cancer	0.00187	0.0238	CbGeAlD
Granisetron—HTR3A—head—brain cancer	0.00161	0.0205	CbGeAlD
Granisetron—Coma—Carmustine—brain cancer	0.00159	0.0072	CcSEcCtD
Granisetron—Infection—Lomustine—brain cancer	0.00155	0.00703	CcSEcCtD
Granisetron—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00154	0.09	CbGpPWpGaD
Granisetron—Thrombocytopenia—Lomustine—brain cancer	0.00153	0.00693	CcSEcCtD
Granisetron—Pain—Carboplatin—brain cancer	0.00153	0.00692	CcSEcCtD
Granisetron—Abnormal vision—Carmustine—brain cancer	0.00152	0.00687	CcSEcCtD
Granisetron—Jaundice—Procarbazine—brain cancer	0.00152	0.00687	CcSEcCtD
Granisetron—Sweating—Procarbazine—brain cancer	0.00149	0.00676	CcSEcCtD
Granisetron—Epistaxis—Procarbazine—brain cancer	0.00147	0.00665	CcSEcCtD
Granisetron—Abnormal vision—Temozolomide—brain cancer	0.00147	0.00664	CcSEcCtD
Granisetron—HTR3A—central nervous system—brain cancer	0.00147	0.0187	CbGeAlD
Granisetron—Body temperature increased—Carboplatin—brain cancer	0.00141	0.0064	CcSEcCtD
Granisetron—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.0014	0.0819	CbGpPWpGaD
Granisetron—Decreased appetite—Lomustine—brain cancer	0.00136	0.00615	CcSEcCtD
Granisetron—Flushing—Procarbazine—brain cancer	0.0013	0.00587	CcSEcCtD
Granisetron—Hyponatraemia—Carmustine—brain cancer	0.00127	0.00574	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00126	0.00572	CcSEcCtD
Granisetron—Dysuria—Hydroxyurea—brain cancer	0.00126	0.00572	CcSEcCtD
Granisetron—Chills—Procarbazine—brain cancer	0.00125	0.00568	CcSEcCtD
Granisetron—Arrhythmia—Procarbazine—brain cancer	0.00125	0.00565	CcSEcCtD
Granisetron—Body temperature increased—Lomustine—brain cancer	0.00124	0.0056	CcSEcCtD
Granisetron—Alopecia—Procarbazine—brain cancer	0.00124	0.00559	CcSEcCtD
Granisetron—Tension—Procarbazine—brain cancer	0.00119	0.0054	CcSEcCtD
Granisetron—Nervousness—Procarbazine—brain cancer	0.00118	0.00535	CcSEcCtD
Granisetron—Liver function test abnormal—Carmustine—brain cancer	0.00117	0.00528	CcSEcCtD
Granisetron—HTR3A—brain—brain cancer	0.00117	0.0149	CbGeAlD
Granisetron—Hypokalaemia—Carmustine—brain cancer	0.00115	0.00521	CcSEcCtD
Granisetron—Tremor—Procarbazine—brain cancer	0.00114	0.00516	CcSEcCtD
Granisetron—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00114	0.00516	CcSEcCtD
Granisetron—Anaemia—Procarbazine—brain cancer	0.00113	0.00509	CcSEcCtD
Granisetron—Hypokalaemia—Temozolomide—brain cancer	0.00111	0.00503	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.0011	0.00498	CcSEcCtD
Granisetron—Syncope—Procarbazine—brain cancer	0.00109	0.00494	CcSEcCtD
Granisetron—Leukopenia—Procarbazine—brain cancer	0.00109	0.00493	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00108	0.00488	CcSEcCtD
Granisetron—Loss of consciousness—Procarbazine—brain cancer	0.00107	0.00484	CcSEcCtD
Granisetron—CYP2D6—brainstem—brain cancer	0.00107	0.0137	CbGeAlD
Granisetron—Abdominal distension—Temozolomide—brain cancer	0.00106	0.00481	CcSEcCtD
Granisetron—Cough—Procarbazine—brain cancer	0.00106	0.00481	CcSEcCtD
Granisetron—Hypertension—Procarbazine—brain cancer	0.00105	0.00475	CcSEcCtD
Granisetron—Arthralgia—Procarbazine—brain cancer	0.00104	0.00469	CcSEcCtD
Granisetron—Anxiety—Procarbazine—brain cancer	0.00103	0.00467	CcSEcCtD
Granisetron—Dry mouth—Procarbazine—brain cancer	0.00101	0.00459	CcSEcCtD
Granisetron—Vomiting—Lomustine—brain cancer	0.000995	0.0045	CcSEcCtD
Granisetron—Oedema—Procarbazine—brain cancer	0.000993	0.00449	CcSEcCtD
Granisetron—Dysuria—Temozolomide—brain cancer	0.000988	0.00447	CcSEcCtD
Granisetron—Infection—Procarbazine—brain cancer	0.000987	0.00446	CcSEcCtD
Granisetron—Angiopathy—Hydroxyurea—brain cancer	0.000982	0.00444	CcSEcCtD
Granisetron—Shock—Procarbazine—brain cancer	0.000977	0.00442	CcSEcCtD
Granisetron—Thrombocytopenia—Procarbazine—brain cancer	0.000973	0.0044	CcSEcCtD
Granisetron—Chills—Hydroxyurea—brain cancer	0.000971	0.00439	CcSEcCtD
Granisetron—Tachycardia—Procarbazine—brain cancer	0.00097	0.00439	CcSEcCtD
Granisetron—Photosensitivity reaction—Temozolomide—brain cancer	0.000964	0.00436	CcSEcCtD
Granisetron—Hyperhidrosis—Procarbazine—brain cancer	0.00096	0.00434	CcSEcCtD
Granisetron—Alopecia—Hydroxyurea—brain cancer	0.000956	0.00433	CcSEcCtD
Granisetron—CYP2D6—telencephalon—brain cancer	0.000949	0.0121	CbGeAlD
Granisetron—Urinary tract infection—Carmustine—brain cancer	0.000947	0.00429	CcSEcCtD
Granisetron—Nausea—Lomustine—brain cancer	0.000929	0.0042	CcSEcCtD
Granisetron—Hypotension—Procarbazine—brain cancer	0.000928	0.0042	CcSEcCtD
Granisetron—Urinary tract infection—Temozolomide—brain cancer	0.000915	0.00414	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000905	0.00409	CcSEcCtD
Granisetron—Insomnia—Procarbazine—brain cancer	0.000899	0.00406	CcSEcCtD
Granisetron—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000896	0.0525	CbGpPWpGaD
Granisetron—Paraesthesia—Procarbazine—brain cancer	0.000892	0.00404	CcSEcCtD
Granisetron—Hepatobiliary disease—Temozolomide—brain cancer	0.000891	0.00403	CcSEcCtD
Granisetron—Sinusitis—Temozolomide—brain cancer	0.000884	0.004	CcSEcCtD
Granisetron—Somnolence—Procarbazine—brain cancer	0.000883	0.004	CcSEcCtD
Granisetron—Ill-defined disorder—Hydroxyurea—brain cancer	0.000874	0.00395	CcSEcCtD
Granisetron—Anaemia—Hydroxyurea—brain cancer	0.000871	0.00394	CcSEcCtD
Granisetron—Decreased appetite—Procarbazine—brain cancer	0.000864	0.00391	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Etoposide—brain cancer	0.000863	0.0039	CcSEcCtD
Granisetron—Connective tissue disorder—Carmustine—brain cancer	0.00086	0.00389	CcSEcCtD
Granisetron—Malaise—Hydroxyurea—brain cancer	0.00085	0.00384	CcSEcCtD
Granisetron—Constipation—Procarbazine—brain cancer	0.00085	0.00384	CcSEcCtD
Granisetron—Pain—Procarbazine—brain cancer	0.00085	0.00384	CcSEcCtD
Granisetron—Leukopenia—Hydroxyurea—brain cancer	0.000843	0.00381	CcSEcCtD
Granisetron—Visual impairment—Carmustine—brain cancer	0.000843	0.00381	CcSEcCtD
Granisetron—Connective tissue disorder—Temozolomide—brain cancer	0.000831	0.00376	CcSEcCtD
Granisetron—CYP1A1—endocrine gland—brain cancer	0.000829	0.0106	CbGeAlD
Granisetron—Feeling abnormal—Procarbazine—brain cancer	0.000819	0.0037	CcSEcCtD
Granisetron—CYP1A1—head—brain cancer	0.000819	0.0105	CbGeAlD
Granisetron—Visual impairment—Temozolomide—brain cancer	0.000815	0.00369	CcSEcCtD
Granisetron—Gastrointestinal pain—Procarbazine—brain cancer	0.000812	0.00368	CcSEcCtD
Granisetron—Flushing—Carmustine—brain cancer	0.000812	0.00367	CcSEcCtD
Granisetron—CYP3A5—endocrine gland—brain cancer	0.000811	0.0104	CbGeAlD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000797	0.0036	CcSEcCtD
Granisetron—Discomfort—Hydroxyurea—brain cancer	0.000792	0.00358	CcSEcCtD
Granisetron—Urticaria—Procarbazine—brain cancer	0.000789	0.00357	CcSEcCtD
Granisetron—Body temperature increased—Procarbazine—brain cancer	0.000785	0.00355	CcSEcCtD
Granisetron—Abdominal pain—Procarbazine—brain cancer	0.000785	0.00355	CcSEcCtD
Granisetron—Flushing—Temozolomide—brain cancer	0.000785	0.00355	CcSEcCtD
Granisetron—Arrhythmia—Carmustine—brain cancer	0.000782	0.00354	CcSEcCtD
Granisetron—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000781	0.0458	CbGpPWpGaD
Granisetron—Alopecia—Carmustine—brain cancer	0.000773	0.0035	CcSEcCtD
Granisetron—Oedema—Hydroxyurea—brain cancer	0.000769	0.00348	CcSEcCtD
Granisetron—Angiopathy—Temozolomide—brain cancer	0.000767	0.00347	CcSEcCtD
Granisetron—Infection—Hydroxyurea—brain cancer	0.000764	0.00346	CcSEcCtD
Granisetron—Malnutrition—Carmustine—brain cancer	0.000762	0.00345	CcSEcCtD
Granisetron—Chills—Temozolomide—brain cancer	0.000759	0.00343	CcSEcCtD
Granisetron—Nervous system disorder—Hydroxyurea—brain cancer	0.000754	0.00341	CcSEcCtD
Granisetron—Thrombocytopenia—Hydroxyurea—brain cancer	0.000753	0.00341	CcSEcCtD
Granisetron—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000751	0.044	CbGpPWpGaD
Granisetron—CYP1A1—central nervous system—brain cancer	0.000747	0.00954	CbGeAlD
Granisetron—Alopecia—Temozolomide—brain cancer	0.000747	0.00338	CcSEcCtD
Granisetron—Skin disorder—Hydroxyurea—brain cancer	0.000747	0.00338	CcSEcCtD
Granisetron—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.000738	0.0433	CbGpPWpGaD
Granisetron—Malnutrition—Temozolomide—brain cancer	0.000736	0.00333	CcSEcCtD
Granisetron—Jaundice—Etoposide—brain cancer	0.000735	0.00332	CcSEcCtD
Granisetron—Hypersensitivity—Procarbazine—brain cancer	0.000732	0.00331	CcSEcCtD
Granisetron—Dysgeusia—Temozolomide—brain cancer	0.000721	0.00326	CcSEcCtD
Granisetron—Tremor—Carmustine—brain cancer	0.000714	0.00323	CcSEcCtD
Granisetron—Asthenia—Procarbazine—brain cancer	0.000713	0.00322	CcSEcCtD
Granisetron—Hepatobiliary disease—Etoposide—brain cancer	0.000713	0.00322	CcSEcCtD
Granisetron—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00071	0.0416	CbGpPWpGaD
Granisetron—Anaemia—Carmustine—brain cancer	0.000704	0.00318	CcSEcCtD
Granisetron—Pruritus—Procarbazine—brain cancer	0.000703	0.00318	CcSEcCtD
Granisetron—Agitation—Carmustine—brain cancer	0.0007	0.00317	CcSEcCtD
Granisetron—Tremor—Temozolomide—brain cancer	0.00069	0.00312	CcSEcCtD
Granisetron—Dyspnoea—Hydroxyurea—brain cancer	0.000685	0.0031	CcSEcCtD
Granisetron—Somnolence—Hydroxyurea—brain cancer	0.000684	0.00309	CcSEcCtD
Granisetron—Ill-defined disorder—Temozolomide—brain cancer	0.000683	0.00309	CcSEcCtD
Granisetron—Leukopenia—Carmustine—brain cancer	0.000682	0.00308	CcSEcCtD
Granisetron—Anaemia—Temozolomide—brain cancer	0.00068	0.00308	CcSEcCtD
Granisetron—Diarrhoea—Procarbazine—brain cancer	0.00068	0.00308	CcSEcCtD
Granisetron—Dyspepsia—Hydroxyurea—brain cancer	0.000677	0.00306	CcSEcCtD
Granisetron—Agitation—Temozolomide—brain cancer	0.000676	0.00306	CcSEcCtD
Granisetron—Decreased appetite—Hydroxyurea—brain cancer	0.000668	0.00302	CcSEcCtD
Granisetron—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000664	0.003	CcSEcCtD
Granisetron—Malaise—Temozolomide—brain cancer	0.000664	0.003	CcSEcCtD
Granisetron—Vertigo—Temozolomide—brain cancer	0.000661	0.00299	CcSEcCtD
Granisetron—Leukopenia—Temozolomide—brain cancer	0.000659	0.00298	CcSEcCtD
Granisetron—Hypertension—Carmustine—brain cancer	0.000658	0.00297	CcSEcCtD
Granisetron—Constipation—Hydroxyurea—brain cancer	0.000658	0.00297	CcSEcCtD
Granisetron—Pain—Hydroxyurea—brain cancer	0.000658	0.00297	CcSEcCtD
Granisetron—Dizziness—Procarbazine—brain cancer	0.000657	0.00297	CcSEcCtD
Granisetron—Palpitations—Temozolomide—brain cancer	0.00065	0.00294	CcSEcCtD
Granisetron—Chest pain—Carmustine—brain cancer	0.000648	0.00293	CcSEcCtD
Granisetron—Anxiety—Carmustine—brain cancer	0.000646	0.00292	CcSEcCtD
Granisetron—Cough—Temozolomide—brain cancer	0.000642	0.00291	CcSEcCtD
Granisetron—Hypertension—Temozolomide—brain cancer	0.000635	0.00287	CcSEcCtD
Granisetron—Feeling abnormal—Hydroxyurea—brain cancer	0.000634	0.00287	CcSEcCtD
Granisetron—Vomiting—Procarbazine—brain cancer	0.000632	0.00286	CcSEcCtD
Granisetron—Flushing—Etoposide—brain cancer	0.000628	0.00284	CcSEcCtD
Granisetron—Arthralgia—Temozolomide—brain cancer	0.000627	0.00283	CcSEcCtD
Granisetron—Rash—Procarbazine—brain cancer	0.000626	0.00283	CcSEcCtD
Granisetron—Dermatitis—Procarbazine—brain cancer	0.000626	0.00283	CcSEcCtD
Granisetron—Anxiety—Temozolomide—brain cancer	0.000624	0.00282	CcSEcCtD
Granisetron—Headache—Procarbazine—brain cancer	0.000622	0.00282	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000622	0.00282	CcSEcCtD
Granisetron—Oedema—Carmustine—brain cancer	0.000622	0.00281	CcSEcCtD
Granisetron—Discomfort—Temozolomide—brain cancer	0.000619	0.0028	CcSEcCtD
Granisetron—Infection—Carmustine—brain cancer	0.000618	0.00279	CcSEcCtD
Granisetron—Angiopathy—Etoposide—brain cancer	0.000614	0.00278	CcSEcCtD
Granisetron—Dry mouth—Temozolomide—brain cancer	0.000613	0.00277	CcSEcCtD
Granisetron—Thrombocytopenia—Carmustine—brain cancer	0.000609	0.00275	CcSEcCtD
Granisetron—CYP3A4—endocrine gland—brain cancer	0.000609	0.00777	CbGeAlD
Granisetron—Body temperature increased—Hydroxyurea—brain cancer	0.000608	0.00275	CcSEcCtD
Granisetron—Chills—Etoposide—brain cancer	0.000607	0.00275	CcSEcCtD
Granisetron—Tachycardia—Carmustine—brain cancer	0.000607	0.00274	CcSEcCtD
Granisetron—Oedema—Temozolomide—brain cancer	0.000601	0.00272	CcSEcCtD
Granisetron—Anaphylactic shock—Temozolomide—brain cancer	0.000601	0.00272	CcSEcCtD
Granisetron—CYP2D6—endocrine gland—brain cancer	0.000599	0.00764	CbGeAlD
Granisetron—Alopecia—Etoposide—brain cancer	0.000598	0.0027	CcSEcCtD
Granisetron—Infection—Temozolomide—brain cancer	0.000597	0.0027	CcSEcCtD
Granisetron—CYP1A1—brain—brain cancer	0.000593	0.00757	CbGeAlD
Granisetron—CYP2D6—head—brain cancer	0.000591	0.00755	CbGeAlD
Granisetron—Nausea—Procarbazine—brain cancer	0.00059	0.00267	CcSEcCtD
Granisetron—Nervous system disorder—Temozolomide—brain cancer	0.000589	0.00266	CcSEcCtD
Granisetron—Thrombocytopenia—Temozolomide—brain cancer	0.000588	0.00266	CcSEcCtD
Granisetron—Skin disorder—Temozolomide—brain cancer	0.000583	0.00264	CcSEcCtD
Granisetron—Hypotension—Carmustine—brain cancer	0.000581	0.00263	CcSEcCtD
Granisetron—Hyperhidrosis—Temozolomide—brain cancer	0.000581	0.00263	CcSEcCtD
Granisetron—Dysgeusia—Etoposide—brain cancer	0.000577	0.00261	CcSEcCtD
Granisetron—Hypersensitivity—Hydroxyurea—brain cancer	0.000566	0.00256	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Carmustine—brain cancer	0.000566	0.00256	CcSEcCtD
Granisetron—Insomnia—Carmustine—brain cancer	0.000562	0.00254	CcSEcCtD
Granisetron—Paraesthesia—Carmustine—brain cancer	0.000558	0.00252	CcSEcCtD
Granisetron—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000556	0.0326	CbGpPWpGaD
Granisetron—Dyspnoea—Carmustine—brain cancer	0.000554	0.00251	CcSEcCtD
Granisetron—Somnolence—Carmustine—brain cancer	0.000553	0.0025	CcSEcCtD
Granisetron—Asthenia—Hydroxyurea—brain cancer	0.000552	0.0025	CcSEcCtD
Granisetron—CYP3A4—central nervous system—brain cancer	0.000548	0.007	CbGeAlD
Granisetron—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000547	0.00248	CcSEcCtD
Granisetron—Ill-defined disorder—Etoposide—brain cancer	0.000546	0.00247	CcSEcCtD
Granisetron—Anaemia—Etoposide—brain cancer	0.000544	0.00246	CcSEcCtD
Granisetron—Insomnia—Temozolomide—brain cancer	0.000543	0.00246	CcSEcCtD
Granisetron—Decreased appetite—Carmustine—brain cancer	0.00054	0.00244	CcSEcCtD
Granisetron—CYP2D6—central nervous system—brain cancer	0.00054	0.00689	CbGeAlD
Granisetron—Paraesthesia—Temozolomide—brain cancer	0.000539	0.00244	CcSEcCtD
Granisetron—Gastrointestinal disorder—Carmustine—brain cancer	0.000537	0.00243	CcSEcCtD
Granisetron—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000536	0.0314	CbGpPWpGaD
Granisetron—Dyspnoea—Temozolomide—brain cancer	0.000536	0.00242	CcSEcCtD
Granisetron—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000534	0.0313	CbGpPWpGaD
Granisetron—Somnolence—Temozolomide—brain cancer	0.000534	0.00242	CcSEcCtD
Granisetron—Pain—Carmustine—brain cancer	0.000532	0.0024	CcSEcCtD
Granisetron—Constipation—Carmustine—brain cancer	0.000532	0.0024	CcSEcCtD
Granisetron—Malaise—Etoposide—brain cancer	0.000531	0.0024	CcSEcCtD
Granisetron—Vertigo—Etoposide—brain cancer	0.000529	0.00239	CcSEcCtD
Granisetron—Dyspepsia—Temozolomide—brain cancer	0.000529	0.00239	CcSEcCtD
Granisetron—CYP2D6—cerebellum—brain cancer	0.000527	0.00673	CbGeAlD
Granisetron—Leukopenia—Etoposide—brain cancer	0.000527	0.00238	CcSEcCtD
Granisetron—Diarrhoea—Hydroxyurea—brain cancer	0.000526	0.00238	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—HES5—brain cancer	0.000524	0.0307	CbGpPWpGaD
Granisetron—Decreased appetite—Temozolomide—brain cancer	0.000522	0.00236	CcSEcCtD
Granisetron—Gastrointestinal disorder—Temozolomide—brain cancer	0.000519	0.00235	CcSEcCtD
Granisetron—Loss of consciousness—Etoposide—brain cancer	0.000518	0.00234	CcSEcCtD
Granisetron—Cough—Etoposide—brain cancer	0.000514	0.00232	CcSEcCtD
Granisetron—Constipation—Temozolomide—brain cancer	0.000514	0.00232	CcSEcCtD
Granisetron—Pain—Temozolomide—brain cancer	0.000514	0.00232	CcSEcCtD
Granisetron—Feeling abnormal—Carmustine—brain cancer	0.000512	0.00232	CcSEcCtD
Granisetron—Hypertension—Etoposide—brain cancer	0.000508	0.0023	CcSEcCtD
Granisetron—Dizziness—Hydroxyurea—brain cancer	0.000508	0.0023	CcSEcCtD
Granisetron—Gastrointestinal pain—Carmustine—brain cancer	0.000508	0.0023	CcSEcCtD
Granisetron—Chest pain—Etoposide—brain cancer	0.000501	0.00227	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000498	0.00225	CcSEcCtD
Granisetron—Discomfort—Etoposide—brain cancer	0.000495	0.00224	CcSEcCtD
Granisetron—Feeling abnormal—Temozolomide—brain cancer	0.000495	0.00224	CcSEcCtD
Granisetron—Body temperature increased—Carmustine—brain cancer	0.000491	0.00222	CcSEcCtD
Granisetron—Abdominal pain—Carmustine—brain cancer	0.000491	0.00222	CcSEcCtD
Granisetron—Gastrointestinal pain—Temozolomide—brain cancer	0.000491	0.00222	CcSEcCtD
Granisetron—Vomiting—Hydroxyurea—brain cancer	0.000489	0.00221	CcSEcCtD
Granisetron—Rash—Hydroxyurea—brain cancer	0.000485	0.00219	CcSEcCtD
Granisetron—Dermatitis—Hydroxyurea—brain cancer	0.000484	0.00219	CcSEcCtD
Granisetron—Headache—Hydroxyurea—brain cancer	0.000482	0.00218	CcSEcCtD
Granisetron—Anaphylactic shock—Etoposide—brain cancer	0.000481	0.00217	CcSEcCtD
Granisetron—Infection—Etoposide—brain cancer	0.000478	0.00216	CcSEcCtD
Granisetron—Urticaria—Temozolomide—brain cancer	0.000477	0.00216	CcSEcCtD
Granisetron—Abdominal pain—Temozolomide—brain cancer	0.000475	0.00215	CcSEcCtD
Granisetron—Body temperature increased—Temozolomide—brain cancer	0.000475	0.00215	CcSEcCtD
Granisetron—Thrombocytopenia—Etoposide—brain cancer	0.000471	0.00213	CcSEcCtD
Granisetron—Tachycardia—Etoposide—brain cancer	0.000469	0.00212	CcSEcCtD
Granisetron—Skin disorder—Etoposide—brain cancer	0.000467	0.00211	CcSEcCtD
Granisetron—Hyperhidrosis—Etoposide—brain cancer	0.000465	0.0021	CcSEcCtD
Granisetron—Hypersensitivity—Carmustine—brain cancer	0.000458	0.00207	CcSEcCtD
Granisetron—Nausea—Hydroxyurea—brain cancer	0.000457	0.00207	CcSEcCtD
Granisetron—Hypotension—Etoposide—brain cancer	0.000449	0.00203	CcSEcCtD
Granisetron—Asthenia—Carmustine—brain cancer	0.000446	0.00202	CcSEcCtD
Granisetron—Hypersensitivity—Temozolomide—brain cancer	0.000443	0.002	CcSEcCtD
Granisetron—Paraesthesia—Etoposide—brain cancer	0.000432	0.00195	CcSEcCtD
Granisetron—Asthenia—Temozolomide—brain cancer	0.000431	0.00195	CcSEcCtD
Granisetron—Dyspnoea—Etoposide—brain cancer	0.000429	0.00194	CcSEcCtD
Granisetron—CYP2D6—brain—brain cancer	0.000428	0.00547	CbGeAlD
Granisetron—Somnolence—Etoposide—brain cancer	0.000427	0.00193	CcSEcCtD
Granisetron—Diarrhoea—Carmustine—brain cancer	0.000425	0.00192	CcSEcCtD
Granisetron—Pruritus—Temozolomide—brain cancer	0.000425	0.00192	CcSEcCtD
Granisetron—Decreased appetite—Etoposide—brain cancer	0.000418	0.00189	CcSEcCtD
Granisetron—Gastrointestinal disorder—Etoposide—brain cancer	0.000415	0.00188	CcSEcCtD
Granisetron—Dizziness—Carmustine—brain cancer	0.000411	0.00186	CcSEcCtD
Granisetron—Constipation—Etoposide—brain cancer	0.000411	0.00186	CcSEcCtD
Granisetron—Pain—Etoposide—brain cancer	0.000411	0.00186	CcSEcCtD
Granisetron—Diarrhoea—Temozolomide—brain cancer	0.000411	0.00186	CcSEcCtD
Granisetron—Dizziness—Temozolomide—brain cancer	0.000397	0.0018	CcSEcCtD
Granisetron—Feeling abnormal—Etoposide—brain cancer	0.000396	0.00179	CcSEcCtD
Granisetron—Vomiting—Carmustine—brain cancer	0.000395	0.00179	CcSEcCtD
Granisetron—Gastrointestinal pain—Etoposide—brain cancer	0.000393	0.00178	CcSEcCtD
Granisetron—Rash—Carmustine—brain cancer	0.000392	0.00177	CcSEcCtD
Granisetron—Dermatitis—Carmustine—brain cancer	0.000392	0.00177	CcSEcCtD
Granisetron—Headache—Carmustine—brain cancer	0.000389	0.00176	CcSEcCtD
Granisetron—Vomiting—Temozolomide—brain cancer	0.000382	0.00173	CcSEcCtD
Granisetron—Urticaria—Etoposide—brain cancer	0.000382	0.00173	CcSEcCtD
Granisetron—Abdominal pain—Etoposide—brain cancer	0.00038	0.00172	CcSEcCtD
Granisetron—Body temperature increased—Etoposide—brain cancer	0.00038	0.00172	CcSEcCtD
Granisetron—Rash—Temozolomide—brain cancer	0.000379	0.00171	CcSEcCtD
Granisetron—Dermatitis—Temozolomide—brain cancer	0.000378	0.00171	CcSEcCtD
Granisetron—Headache—Temozolomide—brain cancer	0.000376	0.0017	CcSEcCtD
Granisetron—Nausea—Carmustine—brain cancer	0.000369	0.00167	CcSEcCtD
Granisetron—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000363	0.0213	CbGpPWpGaD
Granisetron—Nausea—Temozolomide—brain cancer	0.000357	0.00161	CcSEcCtD
Granisetron—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000355	0.0208	CbGpPWpGaD
Granisetron—Hypersensitivity—Etoposide—brain cancer	0.000354	0.0016	CcSEcCtD
Granisetron—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000349	0.0205	CbGpPWpGaD
Granisetron—Asthenia—Etoposide—brain cancer	0.000345	0.00156	CcSEcCtD
Granisetron—Pruritus—Etoposide—brain cancer	0.00034	0.00154	CcSEcCtD
Granisetron—Diarrhoea—Etoposide—brain cancer	0.000329	0.00149	CcSEcCtD
Granisetron—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000324	0.019	CbGpPWpGaD
Granisetron—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00032	0.0188	CbGpPWpGaD
Granisetron—Dizziness—Etoposide—brain cancer	0.000318	0.00144	CcSEcCtD
Granisetron—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000306	0.018	CbGpPWpGaD
Granisetron—Vomiting—Etoposide—brain cancer	0.000306	0.00138	CcSEcCtD
Granisetron—Rash—Etoposide—brain cancer	0.000303	0.00137	CcSEcCtD
Granisetron—Dermatitis—Etoposide—brain cancer	0.000303	0.00137	CcSEcCtD
Granisetron—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000302	0.0177	CbGpPWpGaD
Granisetron—Headache—Etoposide—brain cancer	0.000301	0.00136	CcSEcCtD
Granisetron—Nausea—Etoposide—brain cancer	0.000286	0.00129	CcSEcCtD
Granisetron—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000276	0.0161	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000263	0.0154	CbGpPWpGaD
Granisetron—HTR3A—Ion channel transport—TRPC6—brain cancer	0.000261	0.0153	CbGpPWpGaD
Granisetron—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000249	0.0146	CbGpPWpGaD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000248	0.0146	CbGpPWpGaD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000238	0.0139	CbGpPWpGaD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000231	0.0135	CbGpPWpGaD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000228	0.0133	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000223	0.0131	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—S100A10—brain cancer	0.000197	0.0115	CbGpPWpGaD
Granisetron—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000191	0.0112	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000187	0.011	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—HES1—brain cancer	0.000173	0.0102	CbGpPWpGaD
Granisetron—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000164	0.00959	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000151	0.00884	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000149	0.00872	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.00014	0.00819	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000138	0.00808	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000136	0.00798	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000132	0.00774	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.00013	0.00763	CbGpPWpGaD
Granisetron—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000128	0.00751	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000122	0.00717	CbGpPWpGaD
Granisetron—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000114	0.00666	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP2C9—brain cancer	9.93e-05	0.00582	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	9.8e-05	0.00574	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—TRPC6—brain cancer	9.08e-05	0.00532	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	8.69e-05	0.00509	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	7.85e-05	0.0046	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—brain cancer	7.65e-05	0.00448	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	7.07e-05	0.00415	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.49e-05	0.00381	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.41e-05	0.00375	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	6.01e-05	0.00352	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	5.53e-05	0.00324	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	5.41e-05	0.00317	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	5.41e-05	0.00317	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.07e-05	0.00297	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.71e-05	0.00217	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP2C9—brain cancer	2.39e-05	0.0014	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP2C9—brain cancer	2.26e-05	0.00132	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—BSG—brain cancer	2.03e-05	0.00119	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—BSG—brain cancer	1.92e-05	0.00112	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—IDH1—brain cancer	1.75e-05	0.00102	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP2C9—brain cancer	1.7e-05	0.000996	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—IDH1—brain cancer	1.65e-05	0.000967	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—BSG—brain cancer	1.44e-05	0.000847	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ENO2—brain cancer	1.38e-05	0.000809	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.34e-05	0.000788	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ENO2—brain cancer	1.3e-05	0.000765	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—IDH1—brain cancer	1.24e-05	0.000728	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP2C9—brain cancer	1.11e-05	0.000651	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ENO2—brain cancer	9.82e-06	0.000575	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—BSG—brain cancer	9.44e-06	0.000554	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—IDH1—brain cancer	8.12e-06	0.000476	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ENO2—brain cancer	6.42e-06	0.000376	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CG—brain cancer	6.33e-06	0.000371	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CG—brain cancer	5.98e-06	0.000351	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CG—brain cancer	4.5e-06	0.000264	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CG—brain cancer	2.94e-06	0.000173	CbGpPWpGaD
